Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Japanese Encephalitis (Ixiaro)
  4. 2023
Japanese Encephalitis (Ixiaro)2023

Japanese Encephalitis (Ixiaro) in 2023

27 adverse event reports

Share
27
Reports
0
Deaths
2
Hospitalizations
8
ER Visits
0
Disabilities

2023 Reporting Summary

In 2023, 27 adverse event reports were filed for Japanese Encephalitis (Ixiaro) in VAERS. This represents 4.5% of all 605 reports for this vaccine.

Of these reports, 0 mentioned death, 2 involved hospitalization, 8 required ER visits, and 0 reported disability.

Compared to the average of 55 reports per year for this vaccine, 2023 was below average (-51%).

💡 What This Means

In 2023, reporting for Japanese Encephalitis (Ixiaro) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.

All Years for Japanese Encephalitis (Ixiaro)

YearReportsDeathsHosp.
20195405
20155603

Understanding Yearly Data

•Spikes may reflect awareness: Years with unusual activity (e.g., pandemic) often see increased reporting.
•Dose volume matters: More vaccinations given in a year naturally leads to more reports.
•Reporting lag: Some events are reported months after they occur, so recent years may be incomplete.

Quick Facts

Reports:27
Deaths:0
Hospitalizations:2
% of Total:4.5%
Rank (by vol.):#0 of 2 years
Avg/year:55

Related Pages

Japanese Encephalitis (Ixiaro) Overview35 Years of ReportingCompare Vaccines

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.